Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first.
75,239 questions in 5,342 reviews
current versionsNo studies 15,213 · 20.2%Ungraded 10,323 · 13.7%Very low 17,528 · 23.3%Low 17,951 · 23.9%Moderate 11,190 · 14.9%High 3,034 · 4%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intervention NR Weight gain · patients with diabetic neuropathy Enhanced glucose control for preventing and treating diabetic neuropathy (2012) · Cochrane | RR 1.96 [1.81, 2.13] | 1 study · 10078 participants | High |
Intervention NR Other adverse events · patients with diabetic neuropathy Enhanced glucose control for preventing and treating diabetic neuropathy (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Annual change in peroneal nerve motor conduction velocity m/sec · patients with diabetic neuropathy Enhanced glucose control for preventing and treating diabetic neuropathy (2012) · Cochrane | no estimate extracted | 4 studies · 1371 participants | High |
Intervention NR Annual change in median nerve motor conduction velocity · patients with diabetic neuropathy Enhanced glucose control for preventing and treating diabetic neuropathy (2012) · Cochrane | no estimate extracted | 2 studies · 1241 participants | High |
Intervention NR Annual change in ulnar nerve motor conduction velocity · patients with diabetic neuropathy Enhanced glucose control for preventing and treating diabetic neuropathy (2012) · Cochrane | no estimate extracted | 2 studies · 134 participants | Moderate |
Intervention NR Annual change in vibration threshold in the feet · patients with diabetic neuropathy Enhanced glucose control for preventing and treating diabetic neuropathy (2012) · Cochrane | no estimate extracted | 3 studies · 177 participants | High |
Intervention NR Adverse events · patients with diabetic neuropathy Enhanced glucose control for preventing and treating diabetic neuropathy (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Wide 95% CI. · patients with diabetic neuropathy Enhanced glucose control for preventing and treating diabetic neuropathy (2012) · Cochrane | no estimate extracted | 1 participants | Ungraded |
Intervention NR Annual incidence of clinical neuropathy: risk ratio · patients with diabetic neuropathy Enhanced glucose control for preventing and treating diabetic neuropathy (2012) · Cochrane | no estimate extracted | 4 studies · 6669 participants | High |
Intervention NR Annual change in median nerve motor conduction velocity · patients with diabetic neuropathy Enhanced glucose control for preventing and treating diabetic neuropathy (2012) · Cochrane | no estimate extracted | 1 study · 99 participants | Moderate |
Intervention NR Overall quality of life change score ‐ up to 12 weeks' · Cancer survivors who have completed active cancer treatment Exercise interventions on health‐related quality of life for cancer survivors (2012) · Cochrane | no estimate extracted | 11 studies · 826 participants | Low |
Intervention NR Overall social functioning change ‐ up to 12 weeks' · Cancer survivors who have completed active cancer treatment Exercise interventions on health‐related quality of life for cancer survivors (2012) · Cochrane | no estimate extracted | 5 studies · 386 participants | Very low |
Intervention NR Overall social functioning change ‐ 6 months' · Cancer survivors who have completed active cancer treatment Exercise interventions on health‐related quality of life for cancer survivors (2012) · Cochrane | no estimate extracted | 2 studies · 110 participants | Moderate |
Intervention NR Overall quality of life change score ‐ 6 months' · Cancer survivors who have completed active cancer treatment Exercise interventions on health‐related quality of life for cancer survivors (2012) · Cochrane | no estimate extracted | 2 studies · 115 participants | Moderate |
Intervention NR Overall anxiety change ‐ Up to 12 weeks' · Cancer survivors who have completed active cancer treatment Exercise interventions on health‐related quality of life for cancer survivors (2012) · Cochrane | no estimate extracted | 4 studies · 455 participants | Low |
Intervention NR Overall emotional well‐being/mental health change ‐ up to 12 weeks' · Cancer survivors who have completed active cancer treatment Exercise interventions on health‐related quality of life for cancer survivors (2012) · Cochrane | no estimate extracted | 8 studies · 632 participants | Low |
Intervention NR Overall fatigue change ‐ Up to 12 weeks' · Cancer survivors who have completed active cancer treatment Exercise interventions on health‐related quality of life for cancer survivors (2012) · Cochrane | no estimate extracted | 10 studies · 745 participants | Moderate |
Intervention NR Overall fatigue change ‐ More than 12 weeks less than 6 months' · Cancer survivors who have completed active cancer treatment Exercise interventions on health‐related quality of life for cancer survivors (2012) · Cochrane | no estimate extracted | 3 studies · 246 participants | Low |
Intervention NR Overall pain · Cancer survivors who have completed active cancer treatment Exercise interventions on health‐related quality of life for cancer survivors (2012) · Cochrane | no estimate extracted | 4 studies · 289 participants | Moderate |
Intervention NR Overall sexuality change ‐ 6 months' · Cancer survivors who have completed active cancer treatment Exercise interventions on health‐related quality of life for cancer survivors (2012) · Cochrane | no estimate extracted | 2 studies · 193 participants | Moderate |
Intervention NR Overall sleep disturbance · Cancer survivors who have completed active cancer treatment Exercise interventions on health‐related quality of life for cancer survivors (2012) · Cochrane | no estimate extracted | 8 studies · 438 participants | Moderate |
Intervention NR Death within 5 years · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA) Radiotherapy and chemoradiation after surgery for early cervical cancer (2012) · Cochrane | RR 0.84 [0.3, 2.36] | 2 studies · 397 participants | Moderate |
Intervention NR Disease progression within 5 years · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA) Radiotherapy and chemoradiation after surgery for early cervical cancer (2012) · Cochrane | RR 0.58 [0.37, 0.91] | 2 studies · 397 participants | Moderate |
Intervention NR Haematological adverse events (grade 3 or 4) · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA) Radiotherapy and chemoradiation after surgery for early cervical cancer (2012) · Cochrane | RR 2.38 [0.63, 9.05] | 2 studies · 388 participants | Moderate |
Intervention NR Gastrointestinal adverse events (grade 3 or 4) · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA) Radiotherapy and chemoradiation after surgery for early cervical cancer (2012) · Cochrane | RR 7.32 [0.91, 58.82] | 2 studies · 388 participants | Moderate |
Intervention NR Genitourinary adverse events (grade 3 or 4) · patients with early‐stage cervical cancer (FIGO stages IB1, IB2 or IIA) Radiotherapy and chemoradiation after surgery for early cervical cancer (2012) · Cochrane | RR 2.12 [0.54, 8.37] | 2 studies · 388 participants | Moderate |
Hepatic product (HepaticAid) vs diet only (without supplement) Re‐hospitalisation post liver transplantation [event per patient] · adult patients with malnutrition and encephalopathy before and after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | no estimate extracted | 1 study · 22 participants | Very low |
Standard casein product (Ensure) vs diet only (without supplement) Acute rejection [events per patient] · adult patients with malnutrition and encephalopathy before and after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | no estimate extracted | 1 study · 24 participants | Very low |
Standard casein product (Ensure) vs diet only (without supplement) New onset of diabetes · adult patients with malnutrition and encephalopathy before and after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | no estimate extracted | 1 study · 24 participants | Very low |
Standard casein product (Ensure) vs diet only (without supplement) Length of stay in hospital after liver transplantation · adult patients with malnutrition and encephalopathy before and after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | no estimate extracted | 1 study · 24 participants | Very low |
Standard casein product (Ensure) vs diet only (without supplement) Hepatic encephalopathy related hospitalisation · adult patients with malnutrition and encephalopathy before and after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | no estimate extracted | 1 study · 20 participants | Very low |
Standard casein product (Ensure) vs diet only (without supplement) Changes in grade of hepatic encephalopathy [grade 0‐4] · adult patients with malnutrition and encephalopathy before and after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | no estimate extracted | 1 study · 20 participants | Very low |
Nutritional supplement (500ml) and standard diet vs standard diet alone Mortality during time on waiting list (ITT) · adult patients before and after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | OR 0.24 [0.02, 1.37] | 1 study · 82 participants | Very low |
Nutritional supplement (500ml) and standard diet vs standard diet alone Six months mortality after liver transplantation (ITT) · adult patients before and after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | OR 0.37 [0.06, 1.77] | 1 study · 82 participants | Very low |
Nutritional supplement (500ml) and standard diet vs standard diet alone Mild acute rejection episodes (within 6 months after LTx) · adult patients before and after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | OR 0.56 [0.19, 1.61] | 1 study · 71 participants | Very low |
Nutritional supplement (500ml) and standard diet vs standard diet alone Severe acute rejection episodes (within six months after LTx) · adult patients before and after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | OR 0.63 [0.22, 1.79] | 1 study · 71 participants | Very low |
Enteral immunonutrion with Supportan vs enteral nutrition (EN) with Fresubin Immunological rejection episodes · adult patients after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | no estimate extracted | 1 study · 84 participants | Very low |
Hepatic product (HepaticAid) vs diet only (without supplement) Infections [event per patient] · adult patients with malnutrition and encephalopathy before and after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | no estimate extracted | 1 study · 22 participants | Very low |
Postoperative feeding via nasojejunal tube vs no postoperative parental nutrition (conventional intravenous electrolyte solution) Days in hospital post liver transplantation · adult patients after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | no estimate extracted | 1 study · 31 participants | Very low |
Postoperative feeding via nasojejunal tube vs no postoperative parental nutrition (conventional intravenous electrolyte solution) Re‐hospitalisation [events per patient] · adult patients after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | no estimate extracted | 1 study · 31 participants | Very low |
Postoperative feeding via nasojejunal tube vs no postoperative parental nutrition (conventional intravenous electrolyte solution) Infections (overall) · adult patients after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | OR 0.32 [0.04, 1.86] | 1 study · 31 participants | Very low |
Postoperative feeding via nasojejunal tube vs no postoperative parental nutrition (conventional intravenous electrolyte solution) Infections (bacterial) · adult patients after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | OR 0.41 [0.03, 3.15] | 1 study · 31 participants | Very low |
Postoperative feeding via nasojejunal tube vs no postoperative parental nutrition (conventional intravenous electrolyte solution) Infections (viral) · adult patients after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | no estimate extracted | 1 study · 31 participants | Very low |
Postoperative feeding via nasojejunal tube vs no postoperative parental nutrition (conventional intravenous electrolyte solution) Intensive care unit length of stay after liver transplantation [hours] · adult patients after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | no estimate extracted | 1 study · 31 participants | Very low |
Postoperative feeding via nasojejunal tube vs no postoperative parental nutrition (conventional intravenous electrolyte solution) Time on ventilator [hours until initial extubation] · adult patients after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | no estimate extracted | 1 study · 31 participants | Very low |
Postoperative enteral nutrition (Osmolite) via nasojejunal tube vs postoperative parenteral nutrition (PN) Length of hospital stay after liver transplantation [days] · adult patients after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | no estimate extracted | 1 study · 24 participants | Very low |
Postoperative enteral nutrition (Osmolite) via nasojejunal tube vs postoperative parenteral nutrition (PN) Days on ventilator · adult patients after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | no estimate extracted | 1 study · 24 participants | Very low |
Postoperative enteral nutrition (Osmolite) via nasojejunal tube vs postoperative parenteral nutrition (PN) Mortality · adult patients after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | OR 0.7 [0.01, 60.29] | 1 study · 24 participants | Very low |
Hepatic product (HepaticAid) vs diet only (without supplement) Acute rejection [event per patient] · adult patients with malnutrition and encephalopathy before and after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | no estimate extracted | 1 study · 22 participants | Very low |
Postoperative enteral nutrition (Osmolite) via nasojejunal tube vs postoperative parenteral nutrition (PN) Side effects (vomiting, diarrhoea) · adult patients after liver transplantation. Nutritional interventions for liver‐transplanted patients (2012) · Cochrane | OR 0.68 [0.04, 11.17] | 1 study · 24 participants | Very low |